Emergent BioSolutions (EBS) Misses Q4 EPS by 81c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.52 -0.66%
Financial Fact:
Total other income (expense): -1.93M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total other income (expense): -1.93M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of ($0.43), $0.81 worse than the analyst estimate of $0.38. Revenue for the quarter came in at $148.7 million versus the consensus estimate of $237 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Applied Materials (AMAT) Tops Q3 EPS by 10c, Offers Guidance
- Jefferies on Yeti Holdings Inc. (YETI): 'Reiterate Buy on Today's Weakness'
- Ascendis Pharma (ASND) PT Raised to $333 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
